Levenga, Henriëtte
17  results:
Search for persons X
?
5

Immunogenicity of dendritic cells pulsed with MAGE3, Surviv..:

Hobo, Willemijn ; Strobbe, Leonie ; Maas, Frans...
Cancer Immunology, Immunotherapy.  62 (2013)  8 - p. 1381-1392 , 2013
 
?
7

Partial T Cell-Depleted Allogeneic Stem Cell Transplantatio..:

Levenga, Henriëtte ; Schaap, Nicolaas ; Maas, Frans...
Biology of Blood and Marrow Transplantation.  16 (2010)  3 - p. 320-332 , 2010
 
?
11

Venetoclax consolidation after fixed-duration venetoclax pl..:

Kersting, Sabina ; Dubois, Julie ; Nasserinejad, Kazem...
HOVON CLL study group , Kersting , S , Dubois , J , Nasserinejad , K , Dobber , J A , Mellink , C , van der Kevie-Kersemaekers , A M F , Evers , L M , de Boer , F , Koene , H R , Schreurs , J , van der Klift , M , Velders , G A , van der Spek , E , van der Straaten , H M , Hoogendoorn , M , van Gelder , M , Posthuma , E F M , Visser , H P J , Houtenbos , I , Idink , C A M , Issa , D E , Dompeling , E C , van Zaanen , H C T , Veelken , H , Levenga , H , Tick , L W , Terpstra , W E , Tonino , S H , Boyer , M , Mobasher , M , Levin , M D & Kater , A P 2022 , ' Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe) : primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial ' , The Lancet Haematology , vol. 9 , no. 3 , pp. e190-e199 . https://doi.org/10.1016/S2352-3026(22)00034-5.  , 2022
 
?
12

RANKL inhibition for giant cell lesions of the jaw:A retros..:

Schreuder, Willem H ; Lipplaa, Astrid ; Cleven, Arjen H.G...
https://research.rug.nl/en/publications/96db76a4-2615-40da-b753-5e23d96a9341.  , 2022
 
?
13

Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary b..:

de Groen, A. L ; van Eijk, Ronald ; Bohringer, Stefan...
de Groen , A L , van Eijk , R , Bohringer , S , Wezel , T V , Raghoo , R , Ruano , D , Jansen , P M , Briaire-De Bruijn , I , de Groot , F A , Kleiverda , K , te Boome , L , Terpstra , V , Levenga , H , Nicolae , A , Posthuma , E F M , Focke-Snieders , I , Hardi , L , den Hartog , W C E , Bohmer , L H , Hogendoorn , P C W , den Berg , A V , Diepstra , A , Nijland , M , Lugtenburg , P J , Kersten , M J , Pals , S T , Veelken , H , Bovee , J V M G , Cleven , A H G & Vermaat , J S P 2021 , ' Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype ' , Blood advances , vol. 5 , no. 19 , pp. 3760-3775 . https://doi.org/10.1182/bloodadvances.2021005215.  , 2021
 
?
14

Improving the identification of frail elderly newly diagnos..:

Stege, Claudia A. M ; Nasserinejad, Kazem ; Klein, Saskia K...
https://research.rug.nl/en/publications/6c638995-f6a3-463f-b7bd-2e7ca3dabaac.  , 2021
 
?
15

Improving the identification of frail elderly newly diagnos..:

Stege, Claudia A.M ; Nasserinejad, Kazem ; Klein, Saskia K...
Stege , C A M , Nasserinejad , K , Klein , S K , Timmers , G J , Hoogendoorn , M , Ypma , P F , Nijhof , I S , Velders , G A , Strobbe , L , Durdu-Rayman , N , Westerman , M , Davidis-van Schoonhoven , M A , van Kampen , R J W , Beeker , A , Koster , A , Dijk , A C , van de Donk , N W C J , van der Spek , E , Leys , R B L , Silbermann , M H , Groen , K , van der Burg-de Graauw , N C H P , Sinnige , H A M , van der Hem , K G , Levenga , H , Bilgin , Y M , Sonneveld , P , Levin , M D & Zweegman , S 2021 , ' Improving the identification of frail elderly newly diagnosed multiple myeloma patients ' , Leukemia , vol. 35 , no. 9 , pp. 2715-2719 . https://doi.org/10.1038/s41375-021-01162-z.  , 2021
 
1-15